SCHEMBL19852401

SCHEMBL19852401

C=C(OC)c1ccc(OC2CCNCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.53
HRH3 Q9Y5N1 2/20 0.42
CHEK2 O96017 1/20 0.42
PARP10 Q53GL7 1/20 0.41
IKBKB O14920 1/20 0.40
KCNH2 Q12809 2/20 0.40
ACVR1B P36896 1/20 0.40
TGFBR1 P36897 1/20 0.40
ACVR1 Q04771 1/20 0.40
EPHX2 P34913 3/20 0.39
ROCK1 Q13464 2/20 0.39
ROCK2 O75116 1/20 0.39
PRKACA P17612 1/20 0.39
PRKCD Q05655 1/20 0.39
PRKG1 Q13976 1/20 0.39
PKN1 Q16512 1/20 0.39
PKN2 Q16513 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
CDC42BPA Q5VT25 1/20 0.39
Q6ZSR9 Q6ZSR9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15088391 0.84 HRH1 (0.56) HRH1HRH3CHEK2PARP10IKBKB
SCHEMBL239876 0.81 HRH1 (0.53) HRH1HRH3CHEK2PARP10KCNH2
SCHEMBL19852400 0.81 HRH1 (0.56) HRH1HRH3CHEK2PARP10IKBKB
SCHEMBL942628 0.78 HRH1 (0.66) HRH1HRH3IKBKBKCNH2ACVR1B
SCHEMBL13072384 0.78 HRH1 (0.56) HRH1HRH3CHEK2PARP10IKBKB
SCHEMBL10964232 0.78 HRH1 (0.56) HRH1HRH3CHEK2PARP10IKBKB
SCHEMBL12209632 0.77 HPGD (0.53) HRH1HRH3CHEK2PARP10KCNH2
Hydrochloric Acid SCHEMBL7480710 0.76 HRH1 (0.63) HRH1HRH3IKBKBKCNH2ACVR1B
Hydrochloric Acid SCHEMBL23142001 0.76 HRH1 (0.54) HRH1HRH3CHEK2PARP10IKBKB
SCHEMBL4241025 0.76 HRH1 (0.62) HRH1CHEK2PARP10KCNH2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed